Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
LPCN

Updated 10/6/2026, 9:41 AM ET.

LPCN

Lipocine Inc.

Buy$55,043

Higuchi John W.

Director

25,007 shat $2.20Filed Oct 1, 8:28 PM ETFiling
LPCN

Lipocine Inc.

Buy$27,132

Higuchi John W.

Director

12,561 shat $2.16Filed Sep 30, 8:38 PM ETFiling

Read from public SEC filings. Not financial advice.